Karuna Therapeutics, Inc.

KRTX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$185,823$248,329$206,953$53,048
Short-Term Investments$1,076,990$875,715$287,038$269,282
Receivables$4,900$57$1,750$0
Inventory$32,831$0$0$0
Other Curr. Assets$14,769$2,343$708$1,088
Total Curr. Assets$1,315,313$1,154,769$517,334$344,599
Property Plant & Equip (Net)$20,514$7,875$9,545$2,869
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$261$261$157
Tax Assets$0$1,203$1,661$655
Other NC Assets$382$690$792$157
Total NC Assets$20,896$8,565$10,337$3,026
Other Assets$0$0$0$0
Total Assets$1,336,209$1,163,334$527,671$347,625
Liabilities
Payables$6,783$2,379$1,939$865
Short-Term Debt$2,843$2,282$2,175$844
Tax Payable$0$0$0$0
Deferred Revenue$41,609$0$0$0
Other Curr. Liab.$16,894$29,285$16,099$5,144
Total Curr. Liab.$68,129$33,946$20,213$6,853
LT Debt$13,845$3,046$5,328$1,841
Deferred Rev, NC$0-$1,203-$1,661$0
Deferred Tax Liab, NC$0$1,203$1,661$655
Other NC Liab.$0$104$104-$655
Total NC Liab.$13,845$3,150$5,432$1,841
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$81,974$37,096$25,645$8,694
Equity
Pref Stock$0$0$0$0
Common Stock$4$3$3$3
Retained Earnings-$997,887-$564,207-$287,871-$144,066
AOCI$211-$3,290-$497$39
Other Equity$2,251,907$1,693,732$790,391$482,955
Total Equity$1,254,235$1,126,238$502,026$338,931
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,336,209$1,163,334$527,671$347,625
Net Debt-$169,135-$243,001-$199,450-$50,363
Karuna Therapeutics, Inc. (KRTX) Financial Statements & Key Stats | AlphaPilot